![]() |
|
|





2;
School of Pharmaceutical Sciences, University of Shizuoka, 521, Yada, Shizuoka, 422-8526, Japan;
*
Shizuoka Sangyo University, 41-1, Surugadai, Fujieda, Shizuoka, 426-8668, Japan;
Central Pharmaceutical Research Institute, Japan Tobacco Incorporated 23, Nukogi, Hatano, Kanagawa, 257-0024, Japan;
**
National Institute of Nutrition and Health, 123-1, Toyama, Shinjuku-ku, Tokyo, Japan;
Food Research Laboratories, Mitsui Nohrin Company Limited, 2231, Miyahara, Fujieda, 426-0133, Japan; and

University of Shizuoka, Graduate School of Health Sciences, 521, Yada, Shizuoka, 422 8526, Japan
2To whom correspondence should be addressed. tomitat{at}sea.u-shizuoka-ken.ac.jp
Green tea contains various antioxidative flavan-3ols (tea catechins), such as ()-epigallocatechin gallate (EGCg, the major catechin), which exert potent inhibitory effects on LDL oxidation in vitro and ex vivo in humans. In this study, the antiatherogenic effects of tea catechins were examined in atherosclerosis-susceptible C57BL/6J, apoprotein (apo)E-deficient mice. Male apoE-deficient mice (10 wk old) were fed an atherogenic diet for 14 wk; during that time, one group (tea) was supplied drinking water supplemented with green tea extract (0.8 g/L), and another group (control) was offered the vehicle only. The tea extract consisted of the following (g/100 g): EGCg, 58.4; ()-epigallocatechin (EGC), 11.7; ()-epicatechin (EC), 6.6; ()-gallocatechingallate (GCg), 1.6; ()-epicatechin gallate (ECg), 0.5; and caffeine, 0.4. The estimated actual intake of tea catechin was 1.7 mg/(d · mouse). Tea ingestion did not influence plasma cholesterol or triglyceride concentrations. Plasma lipid peroxides were reduced in the tea group at wk 8, suggesting that the in vivo oxidative state is improved by tea ingestion. Atheromatous areas in the aorta from the arch to the femoral bifurcation and aortic weights were both significantly attenuated by 23% in the tea group compared with the control group. Aortic cholesterol and triglyceride contents were 27 and 50% lower, respectively, in the tea group than in the control group. These results suggest that chronic ingestion of tea extract prevents the development of atherosclerosis without changing the plasma lipid level in apoE-deficient mice, probably through the potent antioxidative activity of the tea.
KEY WORDS: apoprotein Edeficient mice atherosclerosis catechins antioxidants aortic lipids
This article has been cited by other articles:
![]() |
W. O. Song and O. K. Chun Tea Is the Major Source of Flavan-3-ol and Flavonol in the U.S. Diet J. Nutr., August 1, 2008; 138(8): 1543S - 1547S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Murase, S. Haramizu, N. Ota, and T. Hase Tea catechin ingestion combined with habitual exercise suppresses the aging-associated decline in physical performance in senescence-accelerated mice Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R281 - R289. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Abe, Y. Tanaka, N. Fujise, T. Nakamura, H. Masunaga, T. Nagasawa, and M. Yagi An Antioxidative Nutrient-Rich Enteral Diet Attenuates Lethal Activity and Oxidative Stress Induced by Lipopolysaccharide in Mice JPEN J Parenter Enteral Nutr, May 1, 2007; 31(3): 181 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Murase, S. Haramizu, A. Shimotoyodome, I. Tokimitsu, and T. Hase Green tea extract improves running endurance in mice by stimulating lipid utilization during exercise Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1550 - R1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, P. Stillemark-Billton, C. Beck, P. Bostrom, L. Andersson, M. Rutberg, J. Ericsson, B. Magnusson, D. Marchesan, A. Ljungberg, et al. Epigallocatechin gallate increases the formation of cytosolic lipid droplets and decreases the secretion of apoB-100 VLDL J. Lipid Res., January 1, 2006; 47(1): 67 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hirano-Ohmori, R. Takahashi, Y. Momiyama, H. Taniguchi, A. Yonemura, S. Tamai, K. Umegaki, H. Nakamura, K. Kondo, and F. Ohsuzu Green Tea Consumption and Serum Malondialdehyde-Modified LDL Concentrations in Healthy Subjects J. Am. Coll. Nutr., October 1, 2005; 24(5): 342 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. W. Cheng, M. Kuzuya, K. Nakamura, Z. Liu, Q. Di, J. Hasegawa, M. Iwata, T. Murohara, M. Yokota, and A. Iguchi Mechanisms of the Inhibitory Effect of Epigallocatechin-3-Gallate on Cultured Human Vascular Smooth Muscle Cell Invasion Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1864 - 1870. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. El Bedoui, M.-H. Oak, P. Anglard, and V. B. Schini-Kerth Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression Cardiovasc Res, August 1, 2005; 67(2): 317 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Murase, S. Haramizu, A. Shimotoyodome, A. Nagasawa, and I. Tokimitsu Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2005; 288(3): R708 - R715. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ikeda, K. Tsuda, Y. Suzuki, M. Kobayashi, T. Unno, H. Tomoyori, H. Goto, Y. Kawata, K. Imaizumi, A. Nozawa, et al. Tea Catechins with a Galloyl Moiety Suppress Postprandial Hypertriacylglycerolemia by Delaying Lymphatic Transport of Dietary Fat in Rats J. Nutr., February 1, 2005; 135(2): 155 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sies, T. Schewe, C. Heiss, and M. Kelm Cocoa polyphenols and inflammatory mediators Am. J. Clinical Nutrition, January 1, 2005; 81(1): 304S - 312S. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Crespy and G. Williamson A Review of the Health Effects of Green Tea Catechins in In Vivo Animal Models J. Nutr., December 1, 2004; 134(12): 3431S - 3440S. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. W. Cheng, M. Kuzuya, T. Sasaki, S. Kanda, N. Tamaya-Mori, T. Koike, K. Maeda, E. Nishitani, and A. Iguchi Green tea catechins inhibit neointimal hyperplasia in a rat carotid arterial injury model by TIMP-2 overexpression Cardiovasc Res, June 1, 2004; 62(3): 594 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-Y. Chyu, S. M. Babbidge, X. Zhao, R. Dandillaya, A. G. Rietveld, J. Yano, P. Dimayuga, B. Cercek, and P. K. Shah Differential Effects of Green Tea-Derived Catechin on Developing Versus Established Atherosclerosis in Apolipoprotein E-Null Mice Circulation, May 25, 2004; 109(20): 2448 - 2453. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Frei and J. V. Higdon Antioxidant Activity of Tea Polyphenols In Vivo: Evidence from Animal Studies J. Nutr., October 1, 2003; 133(10): 3275S - 3284. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Maron, G. P. Lu, N. S. Cai, Z. G. Wu, Y. H. Li, H. Chen, J. Q. Zhu, X. J. Jin, B. C. Wouters, and J. Zhao Cholesterol-Lowering Effect of a Theaflavin-Enriched Green Tea Extract: A Randomized Controlled Trial Arch Intern Med, June 23, 2003; 163(12): 1448 - 1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baba, N. Osakabe, M. Natsume, Y. Muto, T. Takizawa, and J. Terao In Vivo Comparison of the Bioavailability of (+)-Catechin, (-)-Epicatechin and Their Mixture in Orally Administered Rats J. Nutr., November 1, 2001; 131(11): 2885 - 2891. [Abstract] [Full Text] [PDF] |
||||